Bivalirudin in Acute Myocardial Infarction

Condition:   To Evaluate the Efficacy and Safety of Bivalirudin in AMI Patients With DES Interventions:   Drug: Bivalirudin;   Drug: heparin Sponsor:   Shenzhen Salubris Pharmaceuticals Co., Ltd. Not yet recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials